Gameto
Latest round
- Series C
Last raised
- Jul 2025
Total raised
- $110M
Investors
- 19
About Gameto
Based in Texas, US, and founded in 2020, Gameto, Inc. operates as a biotechnology company that develops healthcare solutions for treating ovarian aging. Dina Radenkovic. Gameto operates an ovarian therapies platform to address the problem of accelerated ovarian aging (granulosa cells & oocytes precursors) by producing human reprogrammed ovarian cells. As of 2022, the platform has three distinct programs: Fertilo, which aims to improve assisted fertility for women; Deovo, which is a first-in-class drug discovery and computational platform for ovarian aging; and Ameno, which aims to make menopause optional. In July 2025, Gameto, Inc.
Who invested in Gameto
19 investors across 5 rounds
See all investors in Gameto
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gameto
Who invested in Gameto?
Gameto has 19 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gameto raised?
Gameto has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Gameto last raise money?
Gameto's most recent round on record is a Series C, in Jul 2025.
What does Gameto do?
Based in Texas, US, and founded in 2020, Gameto, Inc.
Where is Gameto headquartered?
Gameto is headquartered in Austin, US.
Which VCs invest in companies like Gameto?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Gameto's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Gameto? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.